Bone homeostasis depends on a dynamic balance between osteoblast-mediated formation and osteoclast-mediated resorption. Recent advances in osteoimmunology have highlighted immune cells as active regulators of this balance rather than passive bystanders. Neutrophils, abundant in the bone marrow and rapidly recruited to injury or inflammation sites, are now recognized as important modulators of the bone microenvironment. They influence bone remodeling through phagocytosis, degranulation, secretion of cytokines and matrix-related molecules, ROS production, and the formation of neutrophil extracellular traps (NETs).
This review summarizes evidence that neutrophils exert dual, context-dependent effects on osteogenesis and osteoclastogenesis: facilitating repair during acute, well-regulated responses, but contributing to bone loss when activation is aberrant or chronic. Understanding these mechanisms may yield targets for conditions such as osteoporosis, fracture-healing impairment, and inflammatory bone destruction.
Bone remodeling is a cyclical, spatially and temporally coordinated process coupling osteoclast-mediated resorption with osteoblast-driven formation. Osteoblasts arise from mesenchymal stem cells and rely on signaling such as Runx2, Osterix, and Wnt/β-catenin to drive matrix synthesis and mineralization. Osteoclasts differentiate from monocyte-macrophage precursors under M-CSF and RANKL-RANK signaling and resorb mineralized matrix using acid and proteolytic enzymes. The remodeling cycle includes activation, resorption, reversal, formation, and termination phases, with biochemical markers reflecting resorption (eg, CTX, NTX, TRACP5b) and formation (eg, PINP, bone-specific alkaline phosphatase).
Following injury, an inflammatory phase is essential for initiating repair: increased vascular permeability and immune cell recruitment clear debris, stabilize hematoma, promote angiogenesis, and direct MSC homing and osteogenic differentiation via cytokines such as IL-1, IL-6, and TNF-α. However, excessive or unresolved inflammation impairs osteogenesis and enhances osteoclast activity, delaying healing and promoting structural bone loss. The bone marrow microenvironment is therefore both a hematopoietic niche and a regulatory platform for remodeling, with immune cell interactions—previously emphasized for T cells, B cells, and macrophages—now extended to neutrophils.
Neutrophils are produced in the bone marrow via granulopoiesis from granulocyte-monocyte progenitors through successive precursor stages to mature, multilobed circulating neutrophils. Under stress (infection, inflammation, tumors, radiation), emergency granulopoiesis accelerates production and can prematurely release immature neutrophils, increasing heterogeneity in maturation and functional phenotype.
Phenotypic heterogeneity arises from intrinsic factors (developmental stage, cellular age) and extrinsic cues (tissue localization, local microenvironment, circadian signals). As circulating neutrophils age, they acquire features such as decreased CD62L and increased CXCR4, nuclear hypersegmentation, and heightened adhesive/pro-inflammatory potential, influenced by endogenous rhythms and signaling pathways. Tissue-resident or tissue-infiltrating neutrophils further adapt to organ-specific cues, resulting in distinct surface markers and functions compared with circulating cells.
Neutrophils originate from hematopoietic stem and progenitor cells within the bone marrow and proceed through a classical granulopoietic pathway: granulocyte-monocyte progenitors, myeloblasts, promyelocytes, myelocytes, metamyelocytes, band cells, and finally mature segmented neutrophils released to the blood. Emergency granulopoiesis during pathological stress expands granulocytic precursors and leads to the premature appearance of immature neutrophils in circulation, contributing to a heterogeneous pool of neutrophils in both maturation status and effector capability.
Historically seen as short-lived and functionally limited, neutrophils are now recognized as phenotypically plastic. Heterogeneity is not best explained by stable, lineage-committed subsets but rather by a continuum of state-dependent programs determined by maturation, age, tissue context, and microenvironmental signals. The aged phenotype in circulation and tissue-specific adaptation both illustrate how localization and residence time reshape neutrophil behavior. High-resolution profiling has revealed dynamic and reversible functional states instead of a fixed dichotomy.
Functionally, neutrophils can occupy pro-inflammatory or pro-resolving programs. A pro-inflammatory or “N1-like” program emphasizes pathogen clearance and inflammation amplification via enhanced phagocytosis, ROS production, degranulation, and NET formation. These responses are prominent in early acute infection or injury but can cause bystander damage if excessive.
Conversely, an anti-inflammatory or pro-resolving “N2-like” program supports resolution and tissue repair, characterized by increased IL-10, TGF-β, arginase-1, specialized pro-resolving mediators, and annexin A1, with reduced ROS and NET-mediated cytotoxicity. Neutrophils in this state may promote angiogenesis and reparative factor production.
This dichotomy is a simplified functional framework; current evidence favors a spectrum of reversible states shaped by signals in the local microenvironment. Aging induces additional remodeling of neutrophil effector functions (for example, altered MPO content and NET-forming capacity), which can change how neutrophils regulate inflammation and tissue homeostasis.
The bone marrow is both the production site and a regulatory niche where neutrophils interact with osteoblasts, osteoclasts, MSCs, and other immune cells. Neutrophils contribute to bone repair by clearing necrotic tissue, supporting angiogenesis, and modulating MSC behavior during early repair stages. In contrast, in contexts of persistent inflammation, metabolic dysfunction, tumor-associated bone involvement, or aging, neutrophil dysregulation—via inflammatory mediators (TNF-α, IL-1β, IL-6, IL-8), MMP9, ROS, and NETs—can suppress osteogenesis and promote osteoclastogenesis, shifting remodeling toward net bone loss.
Notably, the effects of NETs on bone remodeling are context-dependent: they can either facilitate repair or exacerbate bone destruction depending on the surrounding milieu and disease state. The review emphasizes that neutrophils act as intermediaries linking immune responses to bone remodeling, with activation status and microenvironmental cues largely determining their net effect.
Neutrophils play bidirectional roles in bone metabolism, supporting regeneration in controlled early responses and contributing to bone destruction when chronically or aberrantly activated. Their phenotypic plasticity and context-dependent functional programs underpin these dual effects. Elucidating specific molecular mechanisms and translating this knowledge into therapies for osteoporosis, inflammatory bone loss, and impaired fracture healing remain priorities. The provided source text outlines these conceptual advances but does not include detailed experimental data, therapeutic strategies, or specific mechanistic pathways beyond those summarized here; additional sections of the original article and full figures/tables would be required for more granular details.